Agilent Technologies (NYSE:A) Releases Quarterly Earnings Results

Agilent Technologies (NYSE:A) announced its earnings results on Wednesday. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04, Zacks reports. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The company had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies updated its Q2 2025 guidance to 1.250-1.280 EPS and its FY 2025 guidance to 5.540-5.610 EPS.

Agilent Technologies Stock Up 0.2 %

Agilent Technologies stock opened at $134.51 on Thursday. The firm has a market cap of $38.37 billion, a price-to-earnings ratio of 30.43, a P/E/G ratio of 3.63 and a beta of 1.07. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.09 and a quick ratio of 1.58. Agilent Technologies has a fifty-two week low of $124.16 and a fifty-two week high of $155.35. The firm has a fifty day moving average price of $140.90 and a two-hundred day moving average price of $139.28.

Agilent Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is 22.40%.

Insiders Place Their Bets

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now owns 39,652 shares of the company’s stock, valued at $5,947,800. The trade was a 4.60 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Analyst Upgrades and Downgrades

Several analysts have issued reports on A shares. Barclays raised shares of Agilent Technologies from an “underweight” rating to an “equal weight” rating and boosted their target price for the company from $135.00 to $145.00 in a research note on Monday, February 10th. StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Tuesday, December 24th. Robert W. Baird lowered their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a report on Thursday. Citigroup boosted their price target on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average price target of $146.15.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.